TIMP1 and lung carcinoma: Despite these limitations, we showed that TIMP1 is a sensitive biomarker for lung cancer in mice and humans and we believe that the data presented in this manuscript could have broad implications for early diagnosis, follow up, and stratification of lung cancer patients.